Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 3. B
Eroshkin FM et al. (2024)
|
Xla Wt + neurectoderm explant + stretch
NF14 (RT-PCR)
|
|
|
|
Fig. 5 H
Patel JH et al. (2022)
|
Xtr.Tg(pbin7:GFP) + hif1a MO
NF18 (in situ hybridization)
|
|
|
|
Fig.7.C
Gur M et al. (2022)
|
Xla Wt + aldh1a2 CRISPR
NF12 (RT-PCR)
|
|
|
|
Fig.7.B
Gur M et al. (2022)
|
Xla Wt + aldh1a3 CRISPR
NF10.25 (RT-PCR)
|
|
|
|
Fig.3.A-G
Gur M et al. (2022)
|
Xla Wt + DEAB
NF10.25 (RT-PCR)
|
|
|
|
Fig.1.H
Gur M et al. (2022)
|
Xla Wt + DEAB
NF10.25 (RT-PCR)
|
|
|
|
Fig.3.A-G
Gur M et al. (2022)
|
Xla Wt + Retinoic acid
NF10.25 (RT-PCR)
|
|
|
|
Fig.1.S1.D
Mukherjee S et al. (2020)
|
Xtr Wt + sox17a MO + sox17b.1/b.2 MO
NF10.5 (in situ hybridization)
|
|
|
|
Fig. 4 E
Shah AM et al. (2020)
|
Xla Wt + six1
NF28-32 (in situ hybridization)
|
|
branchiootic syndrome
branchiootorenal syndrome
|
|
Fig. 4 E, Fig. 5 I
Shah AM et al. (2020)
|
Xla Wt + six1
NF28-32 (in situ hybridization)
|
|
branchiootic syndrome
branchiootorenal syndrome
|